Orchard Therapeutics plc
ORTXDelisted Jan 24, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001748907
Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Orchard Therapeutics plc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 35 | 33 | −2 |
| Shares | 5.81M | 5.03M | −778.6K (−13.4%) |
| Value | $31.2M | $26.2M | −$5.00M (−16.0%) |
New holders (4)
Institutions that held Orchard Therapeutics plc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stifel Financial Corp | 28,414 | $148.0K | 0.00% |
| Banque Cantonale Vaudoise | 2,400 | $12.0K | 0.00% |
| Global Retirement Partners, LLC | 2,000 | $10.4K | 0.00% |
| Rhumbline Advisers | 142 | $736 | 0.00% |
Sold out (6)
Institutions that held Orchard Therapeutics plc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Kapitalo Investimentos Ltda | 143,157 | $768.8K |
| Tang Capital Management LLC | 50,000 | $268.5K |
| Forefront Analytics, LLC | 14,654 | $78.7K |
| Sanders Morris Harris LLC | 10,250 | $55.0K |
| Northwestern Mutual Wealth Management Co | 150 | $806 |
| Armstrong Advisory Group, Inc | 5 | $27 |